Rabaca, Baby Boy .
HRN: 29-12-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
06/05/2026
06/12/2026
IV
9.5mg
Q24h
NAMF (maternal UTI)
Checking Final Appropriateness
Indication: Empiric Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes